Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Significant advance in pediatric medicine approved for use in Europe

Feb. 7, 2001

Sigma receptor ligands reported to exert immunosuppressive and other effects

Feb. 6, 2001

Candelalides as Kv1.3 channel blockers and potential immunosuppressants

Feb. 6, 2001

Licensing opportunity from NIH: conjugate cholera vaccines

Feb. 6, 2001

Nabi provides update on StaphVAX progress

Feb. 5, 2001

Immunomodulating imidazoquinolines a focus of R&D at 3M Innovative Properties

Feb. 2, 2001

Licensing opportunity from NIH: neutralization site of HEV and use in vaccination

Jan. 31, 2001

Licensing opportunity from NIH: peptides that stabilize protein antigens

Jan. 31, 2001

Syk inhibitors and their use claimed by Yamanouchi

Jan. 25, 2001

Sagami patents new series of immunosuppressants acting on protein phosphatase

Jan. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...